A Phase IV Study of Thromboembolic and Bleeding Events Following Hip and Knee Arthroplasty Using Oral Factor Xa Inhibitor

Journal of Arthroplasty - United States
doi 10.1016/j.arth.2016.09.021
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Incidence and Time Course of Thromboembolic Outcomes Following Total Hip or Knee Arthroplasty

Archives of Internal Medicine
1998English

Thromboprophylaxis Following Hip and Knee Arthroplasty

Internal Medicine Journal
Internal Medicine
2013English

Antithrombotic Drug and Its Clinical Indication. Factor Xa Inhibitor. Oral Xa Inhibitor (DX-9065a).

Japanese Journal of Clinical Pharmacology and Therapeutics
Pharmacology
1996English

Rivaroxaban: An Oral Direct Inhibitor of Factor Xa

American Journal of Health-System Pharmacy
MedicineHealth PolicyPharmacologyPharmacy
2008English

Thromboembolic and Major Bleeding Events in Relation to Perioperative Bridging of Vitamin K Antagonists in 649 Fast-Track Total Hip and Knee Arthroplasties

Acta Orthopaedica
MedicineSurgeryOrthopedicsSports Medicine
2016English

Outpatient Total Hip and Knee Arthroplasty

Acta Orthopaedica
MedicineSurgeryOrthopedicsSports Medicine
2017English

Risk Factors for Periprosthetic Joint Infection Following Total Hip and Knee Arthroplasty

Journal of Research and Practice on the Musculoskeletal System
2019English

Higher Blood Glucose and Larger Fluctuations Detected Postoperatively Using Continuous Glucose Monitoring: A Preliminary Study Following Total Knee or Hip Arthroplasty

Journal of Experimental Orthopaedics
OrthopedicsSports Medicine
2019English

Effectiveness of Balance Exercises in the Acute Post-Operative Phase Following Total Hip and Knee Arthroplasty: A Randomized Clinical Trial

SAGE Open Medicine
Medicine
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy